- Home
- Publications
- Publication Search
- Publication Details
Title
Involvement of β-arrestins in cancer progression
Authors
Keywords
G protein coupled Receptors, β-Arrestins, Adapter protein, Cancer
Journal
MOLECULAR BIOLOGY REPORTS
Volume 40, Issue 2, Pages 1065-1071
Publisher
Springer Nature
Online
2012-10-17
DOI
10.1007/s11033-012-2148-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Depletion of -Arrestin-2 Promotes Tumor Growth and Angiogenesis in a Murine Model of Lung Cancer
- (2014) S. K. Raghuwanshi et al. JOURNAL OF IMMUNOLOGY
- Stromal Expression of β-Arrestin-1 Predicts Clinical Outcome and Tamoxifen Response in Breast Cancer
- (2011) Katja Lundgren et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- ARRB1-Mediated Regulation of E2F Target Genes in Nicotine-Induced Growth of Lung Tumors
- (2011) Piyali Dasgupta et al. JNCI-Journal of the National Cancer Institute
- Prostaglandin E2 Promotes Lung Cancer Cell Migration via EP4- Arrestin1-c-Src Signalsome
- (2010) J. I. Kim et al. MOLECULAR CANCER RESEARCH
- Prostaglandin E2 Stimulates Human Lung Carcinoma Cell Growth through Induction of Integrin-Linked Kinase: The Involvement of EP4 and Sp1
- (2009) Y. Zheng et al. CANCER RESEARCH
- The prostaglandin receptor EP2 activates multiple signaling pathways and -arrestin1 complex formation during mouse skin papilloma development
- (2009) K.-S. Chun et al. CARCINOGENESIS
- The type III transforming growth factor- receptor negatively regulates nuclear factor kappa B signaling through its interaction with -arrestin2
- (2009) H. J. You et al. CARCINOGENESIS
- Arrestin Development: Emerging Roles for β-arrestins in Developmental Signaling Pathways
- (2009) Jeffrey J. Kovacs et al. DEVELOPMENTAL CELL
- Obestatin stimulates Akt signalling in gastric cancer cells through β-arrestin-mediated epidermal growth factor receptor transactivation
- (2009) Carlos J P Álvarez et al. ENDOCRINE-RELATED CANCER
- Fas Signal Promotes Lung Cancer Growth by Recruiting Myeloid-Derived Suppressor Cells via Cancer Cell-Derived PGE2
- (2009) Y. Zhang et al. JOURNAL OF IMMUNOLOGY
- -Arrestin/Ral Signaling Regulates Lysophosphatidic Acid-Mediated Migration and Invasion of Human Breast Tumor Cells
- (2009) T. T. Li et al. MOLECULAR CANCER RESEARCH
- Deficiency of a β-arrestin-2 signal complex contributes to insulin resistance
- (2009) Bing Luan et al. NATURE
- β-arrestin2 inhibits opioid-induced breast cancer cell death through Akt and caspase-8 pathways
- (2009) M. Zhao et al. NEOPLASMA
- Identification of Arrestin2 as a corepressor of androgen receptor signaling in prostate cancer
- (2009) V. Lakshmikanthan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- β-Arrestin links endothelin A receptor to β-catenin signaling to induce ovarian cancer cell invasion and metastasis
- (2009) Laura Rosanò et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The type III TGF- receptor regulates epithelial and cancer cell migration through -arrestin2-mediated activation of Cdc42
- (2009) K. Mythreye et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effects of COX-2 inhibition on expression of vascular endothelial growth factor and interleukin-8 in lung cancer cells
- (2008) Yong Ming Zhu et al. BMC CANCER
- Novel Role of Thromboxane Receptors Isoform in Bladder Cancer Pathogenesis
- (2008) O. Moussa et al. CANCER RESEARCH
- β-Arrestin and casein kinase 1/2 define distinct branches of non-canonical WNT signalling pathways
- (2008) Vít\[ebreve]zslav Bryja et al. EMBO REPORTS
- Endocytosis of the Type III Transforming Growth Factor-β (TGF-β) Receptor through the Clathrin-independent/Lipid Raft Pathway Regulates TGF-β Signaling and Receptor Down-regulation
- (2008) Elizabeth C. Finger et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started